Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
UBS
Teva
Daiichi Sankyo
Queensland Health
Medtronic
Fuji
Merck
Boehringer Ingelheim

Generated: May 23, 2018

DrugPatentWatch Database Preview

CALCIMAR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Calcimar patents expire, and when can generic versions of Calcimar launch?

Calcimar is a drug marketed by Sanofi Aventis Us and is included in two NDAs.

The generic ingredient in CALCIMAR is calcitonin salmon. There are fourteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.
Summary for CALCIMAR
US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: 5
Formulation / Manufacturing:see details
DailyMed Link:CALCIMAR at DailyMed
Drug patent expirations by year for CALCIMAR
Synonyms for CALCIMAR
9007-12-9
AM000902
Astronin
Biocalcin
Bionocalcin
C06865
C145H239N43O48S2
Cadens
Calciben
Calcihexal
Calcimar (TN)
Calcimonta
Calcinil
Calcioton
Calcitar
Calcitonin (source)
Calcitonin [USAN:INN:BAN:JAN]
Calcitonin [USAN:USP:INN:BAN:JAN]
Calcitonin salmon (JP17/USAN/INN)
Calcitonin salmon (synthesis)
Calcitonin salmon (synthesis) (JAN)
Calcitonin salmon (USAN/INN)
Calcitonin vom lachs
Calcitonin-salmon
Calcitonin, salmar
CALCITONIN, SALMON
Calcitonin, salmon, for bioassay
Calcitonin,salmon
Calcitonina
Calcitonina [INN-Spanish]
Calcitonine [INN-French]
Calcitonine de saumon
Calcitoninum
Calcitoninum [INN-Latin]
Calcitoran
Calcitrin
Calco
Calogen
Calsynar
Calsynar Lyo L
Caltine
Casalm
Catonin
Cibacalcin
Cibacalcine
Citonina
CT (8-32) (salmon)
D00249
D0I1XG
DF35I47HCM
EINECS 232-693-2
EINECS 256-342-8
Eptacalcin
Forcaltonin
Fortical
Fortical (TN)
HSDB 3209
Ipocalcin
Isi-calcin
Kalsimin
Karil
LS-48624
Miacalcic
Miacalcin
Miacalcin (TN)
Miracalcic
Oseototal
Osseocalcina
Osteobion
Osteovis
Ostosalm
Ostostabil
Porostenina
Prontocalcin
Quosten
recombinant salmon calcitonin
Riostin
Rulicalcin
Salcat
Salcatonin
Salcatyn
Salmocalcin
Salmofar
Salmon calcitonin
salmon calcitonin (1-32)
salmon calcitonin (8-32)
Salmon calcitonin I
Salmon calcitonin-(I-32)
SCHEMBL269785
Sical
Stalcin
Staporos
Steocin
synthetic salmon calcitonin
Thyrocalcitonin (salmon)
Thyrocalcitonin (source)
Tonocalcin
TZ-CT
Ucecal
UNII-DF35I47HCM

US Patents and Regulatory Information for CALCIMAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us CALCIMAR calcitonin salmon INJECTABLE;INJECTION 017769-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us CALCIMAR calcitonin salmon INJECTABLE;INJECTION 017497-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Dow
Express Scripts
Federal Trade Commission
Cipla
Healthtrust
Covington
Deloitte
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.